StemGen Valuation
| SGNI Stock | USD 0.10 0.00 0.00% |
StemGen seems to be overvalued based on Macroaxis valuation methodology. Our model measures the value of StemGen from inspecting the company fundamentals such as Price To Earning of (11.53) X, shares outstanding of 45.67 M, and Return On Asset of -0.8 as well as reviewing its technical indicators and probability of bankruptcy.
Overvalued
Today
Please note that StemGen's price fluctuation is very steady at this time. Calculation of the real value of StemGen is based on 3 months time horizon. Increasing StemGen's time horizon generally increases the accuracy of value calculation and significantly improves the predictive power of the methodology used.
Since StemGen is currently traded on the exchange, buyers and sellers on that exchange determine the market value of StemGen Pink Sheet. However, StemGen's intrinsic value may or may not be the same as its current market price, in which case there is an opportunity to profit from the mispricing, assuming the market price will eventually merge with its intrinsic value. | Historical | Market 0.1 | Real 0.084 | Hype 0.1 | Naive 0.1 |
The intrinsic value of StemGen's stock can be calculated using various methods such as discounted cash flow or dividend analysis. That value may differ from its market price, which is determined by factors such as investor sentiment, market trends, headlines, and other external factors that may influence StemGen's stock price.
Estimating the potential upside or downside of StemGen helps investors to forecast how StemGen pink sheet's addition to their portfolios will impact the overall performance. We also use other valuation drivers to help us estimate the true value of StemGen more accurately as focusing exclusively on StemGen's fundamentals will not take into account other important factors: StemGen Total Value Analysis
StemGen is at this time estimated to have valuation of 5.11 M with market capitalization of 4.57 M, debt of 828.02 K, and cash on hands of 22.87 K. Please note that valuation may be misleading and is a subject to auditing or accounting errors. We encourage investors to vigilantly validate all of the StemGen fundamentals before making equity appraisal based on enterprise value of the company| Takeover Price | Market Cap | Debt Obligations | Cash |
5.11 M | 4.57 M | 828.02 K | 22.87 K |
StemGen Investor Information
About 75.0% of the company outstanding shares are owned by corporate insiders. The company recorded a loss per share of 0.01. StemGen had not issued any dividends in recent years. The entity had 1:80 split on the 5th of February 2013. Based on the analysis of StemGen's profitability, liquidity, and operating efficiency, StemGen is not in a good financial situation at this time. It has a very high probability of going through financial hardship in January.StemGen Asset Utilization
The asset utilization indicator refers to the revenue earned for every dollar of assets a company currently reports. StemGen has an asset utilization ratio of 9.71 percent. This signifies that the Company is making $0.0971 for each dollar of assets. An increasing asset utilization means that StemGen is more efficient with each dollar of assets it utilizes for everyday operations.StemGen Ownership Allocation
StemGen shows a total of 45.67 Million outstanding shares. StemGen has majority of its outstanding shares owned by insiders. An insider is usually defined as a corporate executive, director, member of the board or institutional investor who own at least 10% of the company's outstanding shares. 75.27 % of StemGen outstanding shares that are owned by insiders indicates they have been buying or selling the stock in recent months in anticipation of some upcoming event. Please note that no matter how many assets the company owns, if the real value of the company is less than the current market value, you may not be able to make money on it.StemGen Profitability Analysis
The company reported the previous year's revenue of 39 K. Net Loss for the year was (433.14 K) with profit before overhead, payroll, taxes, and interest of 8.55 K.About StemGen Valuation
An absolute valuation paradigm, as applied to StemGen Pink Sheet, attempts to find the value of StemGen based on its fundamental and basic technical indicators. By analyzing StemGen's financials, quarterly and monthly indicators, and their related drivers, such as dividends, operating cash flow, and various types of growth rates, we attempt to find the most accurate representation of StemGen's intrinsic value. In some cases, mostly for established, large-cap companies, we also incorporate more traditional valuation methods such as dividend discount, discounted cash flow, or asset-based models. As compared to an absolute model, our relative valuation model uses a comparative analysis of StemGen. We calculate exposure to StemGen's market risk, different technical and fundamental indicators, and relevant financial multiples and ratios and then compare them to those of StemGen's related companies.StemGen, Inc. engages in the community offering and management of online competitions in the motorsports arena. The company offers a virtual to real platform in the motorsports industry. Stemgen operates under Electronic Gaming Multimedia classification in the United States and is traded on OTC Exchange. It employs 1 people.
8 Steps to conduct StemGen's Valuation Analysis
Company's valuation is the process of determining the worth of any company in monetary terms. It estimates StemGen's potential worth based on factors such as financial performance, market conditions, growth prospects, and overall economic environment. The result of company valuation is a single number representing a Company's current market value. This value can be used as a benchmark for various financial transactions such as mergers and acquisitions, initial public offerings (IPOs), or private equity investments. To conduct StemGen's valuation analysis, follow these 8 steps:- Gather financial information: Obtain StemGen's financial statements, including balance sheets, income statements, and cash flow statements.
- Determine StemGen's revenue streams: Identify StemGen's primary sources of revenue, including products or services offered, target markets, and pricing strategies.
- Analyze market data: Research StemGen's industry and market trends, including the size of the market, growth rate, and competition.
- Establish StemGen's growth potential: Evaluate StemGen's management, business model, and growth potential.
- Determine StemGen's financial performance: Analyze its financial statements to assess its historical performance and future potential.
- Choose a valuation method: Consider the Company's specific circumstances and choose an appropriate valuation method, such as the discounted cash flow (DCF) or comparable analysis method.
- Calculate the value: Apply the chosen valuation method to the financial information and market data to calculate StemGen's estimated value.
- Review and adjust: Review the results and make necessary adjustments, considering any relevant factors that may have been missed or overlooked.
StemGen Growth Indicators
Growth stocks usually refer to those companies expected to grow sales and earnings faster than the market average. Growth stocks typically don't pay dividends, often look expensive, and usually trading at a high P/E ratio. Nevertheless, such valuations could be relatively cheap if the company continues to grow, which will drive the share price up. However, since most investors are paying a high price for a growth stock, based on expectations, if those expectations are not fully realized, growth stocks can see dramatic declines.
| Common Stock Shares Outstanding | 45.6 M | |
| Retained Earnings | -1.1 M |
Complementary Tools for StemGen Pink Sheet analysis
When running StemGen's price analysis, check to measure StemGen's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy StemGen is operating at the current time. Most of StemGen's value examination focuses on studying past and present price action to predict the probability of StemGen's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move StemGen's price. Additionally, you may evaluate how the addition of StemGen to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Efficient Frontier Plot and analyze your portfolio and positions against risk-return landscape of the market. | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges | |
| Top Crypto Exchanges Search and analyze digital assets across top global cryptocurrency exchanges | |
| Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios |